United Therapeutics Corp at Cowen Healthcare Conference (Virtual) Transcript
Hi, everyone, and thank you for joining us at Cowen and Company's 41st Annual Healthcare Conference. I'm Joe Thome, the senior biotech analyst on the team. And it is my pleasure to have with me today the team from United Therapeutics, Mike Benkowitz, President and CEO; James Edgemond, CFO and Treasurer; and the Head of Investor Relations, Dewey Steadman. To kick things off, I will turn it over to Dewey, who has some forward-looking statements to announce.
Hi, good morning. Our remarks today may include forward-looking information about our business, and please see our SEC filings for risks and uncertainties that could cause actual results to differ. Thanks, Joe.
Great. And Michael, just to start with you. Definitely been a lot of progress over the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |